Concepedia

Jessica O’Keeffe

JO

Statistics

Publications

7

Citations

235

H-Index

7

Active since

1994

Affiliations

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(Current)

Pfizer (United States)

Jessica O’Keeffe is an author at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

1994–2023

7

Publications

7

Fluconazole treatment of neonates and infants with severe fungal infections not treatable with conventional agents

C. Fasano, Jessica O’Keeffe, David L. Gibbs · European Journal of Clinical Microbiology & Infectious Diseases · 1994 · 73 citations

, , +6

A Phase I Study of IDH305 in Patients with Advanced Malignancies Including Relapsed/Refractory AML and MDS That Harbor IDH1R132 Mutations

Courtney D. DiNardo, Aaron D. Schimmer, Karen Yee et al. · Blood · 2016 · 59 citations

Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM).

J. G. Berdeja, Sikander Ailawadhi, Steven Weitman et al. · Journal of Clinical Oncology · 2011 · 36 citations

, , +17

Fluconazole treatment of children with severe fungal infections not treatable with conventional agents

C. Fasano, Jessica O’Keeffe, David L. Gibbs · European Journal of Clinical Microbiology & Infectious Diseases · 1994 · 24 citations

, , +7

First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors

Rom S. Leidner, Kevin C. Conlon, Douglas G. McNeel et al. · Journal for ImmunoTherapy of Cancer · 2023 · 22 citations · Full text

1–5 of 7